DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
All Clinical Trials for Theophylline 0.04% And Dextrose 5% In Plastic Container
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000575 | Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) | Completed | CAMP Steering Committee | Phase 3 | 1991-09-01 | The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development. |
| NCT00000575 | Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1991-09-01 | The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development. |
| NCT00000575 | Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) | Completed | Johns Hopkins Bloomberg School of Public Health | Phase 3 | 1991-09-01 | The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development. |
| NCT00000577 | Asthma Clinical Research Network (ACRN) | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1993-09-01 | This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Theophylline 0.04% And Dextrose 5% In Plastic Container
Clinical Trial Locations for Theophylline 0.04% And Dextrose 5% In Plastic Container
Trials by Country
Trials by US State
Clinical Trial Progress for Theophylline 0.04% And Dextrose 5% In Plastic Container
Clinical Trial Sponsors for Theophylline 0.04% And Dextrose 5% In Plastic Container
Sponsor Name
| Sponsor Name for Theophylline 0.04% And Dextrose 5% In Plastic Container | |
| Sponsor | Trials |
| National Heart, Lung, and Blood Institute (NHLBI) | 8 |
| Boehringer Ingelheim | 4 |
| The First Affiliated Hospital of Guangzhou Medical University | 4 |
| [disabled in preview] | 3 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Export unavailable in trial.
Subscribe for complete access.
